Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2007
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2301174C A method for inducing therapeutically-effective proteins
11/27/2007CA2292600C Compositions and methods for inhibiting photoaging of skin
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007CA2267932C Compositions for postgastrectomic mineral supply
11/22/2007WO2007133771A2 Multipurpose adiabatic potable water production apparatus and methods
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132873A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
11/22/2007WO2007132867A1 Prophylactic and therapeutic agent for cancer
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132784A1 Antipsychotic drug and remedy for cognitive abnormality containing anthraquinone derivative as the active ingredient
11/22/2007WO2007132555A1 Cell membrane-permeable peptide and utilization of the same in cell
11/22/2007WO2007131592A1 Combinations of erdosteine and beta-2 agonists for treating copd
11/22/2007WO2007112138A3 Method of using guava extract and composition including guava extract
11/22/2007WO2006135839A3 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
11/22/2007WO2006100208A9 1-benzylindole-2-carboxamide derivatives
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070270491 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
11/22/2007US20070270489 Remedy for Cartilage-Related Diseases
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270469 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270468 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270462 8-hydroxyquinoline compounds for treating a polyglutamine (polyQ)-expansion disease
11/22/2007US20070270459 Overactive bladder treating drug
11/22/2007US20070270441 Combination
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270435 Novel Compounds
11/22/2007US20070270432 Novel Method
11/22/2007US20070270425 Substituted pyrimidinyl oxime kinase inhibitors
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270393 Methods and compositions for modulation of sleep cycle
11/22/2007US20070270392 Use of a Cyclopentenone Prostaglandin for Delaying the Onset and/or Preventing the Continuation of Labour
11/22/2007US20070270391 2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270372 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested
11/22/2007US20070270371 Dosing and scheduling of oligomers
11/22/2007US20070270370 Novel bicyclonucleoside analogues
11/22/2007US20070270369 An antisense nucleic acid or an small interfering RNA (siRNA) that inhibits interaction of survivin with hepatitis B X-interacting protein (HBXIP);modified backbone comprises phosphorothioates; antiapoptosis; anticarcinogenic agents; antitumor agents; viricides; tissue-targeted therapy
11/22/2007US20070270364 Helicases
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270340 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269527 Therapeutic agents for low HDL-cholesterolemia
11/22/2007US20070269525 O/W Gel Compositions Comprising Wax
11/22/2007US20070269522 Transdermal Drug Delivery Device with Translucent Protective Film
11/22/2007US20070269521 Tooth whitening strips
11/22/2007US20070269520 Tooth whitening strips
11/22/2007US20070269515 Probiotic Tablet Formulations
11/22/2007US20070269502 Stable Liposome Compositions Comprising Lipophilic Amine Containing Pharmaceutical Agents
11/22/2007US20070269498 New Dressing Material Promoting Recovery Of Skin Wound
11/22/2007US20070269491 Tooth whitening strips
11/22/2007US20070269489 Extracorporeal cell-based therapeutic device and delivery system
11/22/2007US20070269452 Methods and compositions for the diagnosis and treatment of cancer
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269406 Transcatheter tumor immunoembolization
11/22/2007US20070269382 Nanoparticles and Their Use for Multifunctional Bioimaging
11/22/2007US20070269378 Nadks as Modifiers of Branching Morphogenesis and Methods of Use
11/22/2007US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007CA2652328A1 Prophylactic and therapeutic agent for cancer
11/21/2007EP1857817A1 Screening method
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857544A1 Pluripotent stem cell derived from cardiac tissue
11/21/2007EP1857457A2 Benzimidazole derivative and its use as AII receptor antagonist
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857447A1 Ppar-activating compound
11/21/2007EP1857446A1 Novel hsp90 inhibitor
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857108A1 Preventive or therapeutic agent for herpesvirus-related disease
11/21/2007EP1857106A1 Combinations of erdosteine and beta-2 agonists for treating COPD
11/21/2007EP1855665A1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease
11/21/2007EP1855663A2 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1490077B1 A photoprotective orally administrable composition for skin
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1458368B1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1423102B1 Plaster for the treatment of dysfunctions and disorders of nail growth
11/21/2007EP1405639B1 Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1319064B1 Gsk3 polypeptides
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1197226B1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
11/21/2007EP1188445B1 Drug composition containing lecithin-modified superoxide dismutase
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007EP0842196B1 Cell adhesion inhibitors
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 1564